Cardiac complication after experimental human malaria infection: a case report

A 20 year-old healthy female volunteer participated in a clinical Phase I and IIa safety and efficacy trial with candidate malaria vaccine PfLSA-3-rec adjuvanted with aluminium hydroxide. Eleven weeks after the third and last immunization she was experimentally infected by bites of Plasmodium falcip...

Descripción completa

Detalles Bibliográficos
Autores principales: Nieman, An-Emmie, de Mast, Quirijn, Roestenberg, Meta, Wiersma, Jorien, Pop, Gheorghe, Stalenhoef, Anton, Druilhe, Pierre, Sauerwein, Robert, van der Ven, André
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Case report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2794284/
https://www.ncbi.nlm.nih.gov/pubmed/19958549
http://dx.doi.org/10.1186/1475-2875-8-277

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2794284/
https://www.ncbi.nlm.nih.gov/pubmed/19958549
http://dx.doi.org/10.1186/1475-2875-8-277

Ejemplares similares